As of June 14, 2025, Esprinet SpA's estimated intrinsic value ranges from $1.75 to $10.33 per share, depending on the valuation methodology applied.
Valuation Method | Fair Value (USD) | Implied Upside/Downside |
---|---|---|
Discounted Cash Flow (10Y) | $8.25 | +122.4% |
Discounted Cash Flow (5Y) | $7.30 | +96.9% |
Dividend Discount Model (Multi-Stage) | $1.75 | -52.9% |
Dividend Discount Model (Stable) | $1.90 | -48.8% |
Earnings Power Value | $10.33 | +178.5% |
Is Esprinet SpA (PRT.MI) undervalued or overvalued?
With the current market price at $3.71, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Esprinet SpA's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
WACC Component | Low | High |
---|---|---|
Long-term bond rate | 3.7% | 4.2% |
Equity market risk premium | 8.3% | 9.3% |
Adjusted beta | 1.32 | 1.61 |
Cost of equity | 14.6% | 19.6% |
Cost of debt | 4.0% | 5.4% |
Tax rate | 25.4% | 26.3% |
Debt/Equity ratio | 1.36 | 1.36 |
After-tax WACC | 7.9% | 10.6% |
Our DCF model projects cash flows over 5-year and 10-year horizons, with the following key assumptions:
DCF Model | Fair Value | Enterprise Value | % from Terminal Value |
---|---|---|---|
5-Year Growth | $7 | $414M | 65.4% |
10-Year Growth | $8 | $462M | 45.4% |
5-Year EBITDA | $6 | $368M | 61.0% |
10-Year EBITDA | $7 | $421M | 40.1% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
EPV Component | Value |
---|---|
Normalized Earnings | $51M |
Discount Rate (WACC) | 10.6% - 7.9% |
Enterprise Value | $484M - $650M |
Net Debt | $46M |
Equity Value | $438M - $604M |
Outstanding Shares | 50M |
Fair Value | $9 - $12 |
Selected Fair Value | $10.33 |
Metric | Value |
---|---|
Market Capitalization | $187M |
Enterprise Value | $233M |
Trailing P/E | 9.94 |
Forward P/E | 8.29 |
Trailing EV/EBITDA | 5.75 |
Current Dividend Yield | 0.00% |
Dividend Growth Rate (5Y) | 33.04% |
Debt-to-Equity Ratio | 1.36 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
Valuation Method | Weight | Weighted Value |
---|---|---|
Discounted Cash Flow (10Y) | 30% | $2.48 |
Discounted Cash Flow (5Y) | 25% | $1.83 |
Dividend Discount Model (Multi-Stage) | 20% | $0.35 |
Dividend Discount Model (Stable) | 15% | $0.28 |
Earnings Power Value | 10% | $1.03 |
Weighted Average | 100% | $5.97 |
Based on our comprehensive valuation analysis, Esprinet SpA's weighted average intrinsic value is $5.97, which is approximately 60.9% above the current market price of $3.71.
Key investment considerations:
Given these factors, we believe Esprinet SpA is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.